The duration of viral suppression during protease inhibitor therapy for HIV-1 infection is predicted by plasma HIV-1 RNA at the nadir-Reference-Cited by-同舟云学术

The duration of viral suppression during protease inhibitor therapy for HIV-1 infection is predicted by plasma HIV-1 RNA at the nadir

Published:1998-03 Issue:5 Volume:12 Page:F9-F14
ISSN:0269-9370
Container-title:AIDS
language:en
Short-container-title:AIDS

Author:

Kempf Dale J.,Rode Richard A.,Xu Yi,Sun Eugene,Heath-Chiozzi Margo E.,Valdes Joaquin,Japour Anthony J.,Danner Sven,Boucher Charles,Molla Akhteruzzaman,Leonard John M.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Infectious Diseases,Immunology,Immunology and Allergy

Reference14 articles.

1. A Controlled Trial of Two Nucleoside Analogues plus Indinavir in Persons with Human Immunodeficiency Virus Infection and CD4 Cell Counts of 200 per Cubic Millimeter or Less

2. Treatment with Indinavir, Zidovudine, and Lamivudine in Adults with Human Immunodeficiency Virus Infection and Prior Antiretroviral Therapy

3. Ordered accumulation of mutations in HIV protease confers resistance to ritonavir

4. In vivo emergence of HIV-1 variants resistant to multiple protease inhibitors

5. Active human immunodeficiency virus protease is required for viral infectivity.

Cited by 201 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Analyzing Longitudinally Collected Viral Load Measurements in Youth With Perinatally Acquired HIV Infection: Problems and Possible Remedies;American Journal of Epidemiology;2022-07-22

2. Selection of HIV-1 for Resistance to Fourth Generation Protease Inhibitors Reveals Two Independent Pathways to High-Level Resistance;2019-11-09

3. GII.4 Norovirus Protease Shows pH-Sensitive Proteolysis with a Unique Arg-His Pairing in the Catalytic Site;Journal of Virology;2019-03-15

4. HIV-Infektion;Zentralblatt für Arbeitsmedizin, Arbeitsschutz und Ergonomie;2016-12-19

5. Long-term immune and virological response in HIV-infected patients receiving antiretroviral therapy;Journal of Clinical Pharmacy and Therapeutics;2016-09-27